CD163 and glioblastoma: However, to better reconstitute the heterogeneity of GBM tissue and the tumour microenvironment we would propose to develop cancer cell lines that are BTK+/SOX2+ and BTK−/SOX2+, along with BTK+/CD163+ and BTK−/CD163+ immune cell populations.